Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exodif (tolevamer) in CDAD
NCT00466635Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Apr 2007
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tolevamer potassium-sodium in Clostridium difficile infection (CDI), sponsored by Sanofi. Started Apr 2007; status: terminated.
02
Drugs
tolevamer potassium-sodium
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT00466635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466635.